Bacteriomimetic invasin-functionalized nanocarriers for intracellular delivery.
dc.contributor.author | Labouta, Hagar Ibrahim | |
dc.contributor.author | Menina, Sara | |
dc.contributor.author | Kochut, Annika | |
dc.contributor.author | Gordon, Sarah | |
dc.contributor.author | Geyer, Rebecca | |
dc.contributor.author | Dersch, Petra | |
dc.contributor.author | Lehr, Claus-Michael | |
dc.date.accessioned | 2016-02-09T13:56:58Z | en |
dc.date.available | 2016-02-09T13:56:58Z | en |
dc.date.issued | 2015-12-28 | en |
dc.identifier.citation | Bacteriomimetic invasin-functionalized nanocarriers for intracellular delivery. 2015, 220 (Pt A):414-24 J Control Release | en |
dc.identifier.issn | 1873-4995 | en |
dc.identifier.pmid | 26522071 | en |
dc.identifier.doi | 10.1016/j.jconrel.2015.10.052 | en |
dc.identifier.uri | http://hdl.handle.net/10033/595959 | en |
dc.description.abstract | Intracellular bacteria invade mammalian cells to establish an infectious niche. The current work models adhesion and subsequent internalization strategy of pathogenic bacteria into mammalian cells to design a bacteriomimetic bioinvasive delivery system. We report on the surface functionalization of liposomes with a C-terminal fragment of invasin (InvA497), an invasion factor in the outer membrane of Yersinia pseudotuberculosis. InvA497-functionalized liposomes adhere to mammalian epithelial HEp-2 cell line at different infection stages with a significantly higher efficiency than liposomes functionalized with bovine serum albumin. Covalent attachment of InvA497 results in higher cellular adhesion than liposomes with physically adsorbed InvA497 with non-specific surface protein alignment. Uptake studies in HEp-2 cells indicate active internalization of InvA497-functionalized liposomes via β1-integrin receptor-mediated uptake mechanism mimicking the natural invasion strategy of Y. pseudotuberculosis. Uptake studies in Caco-2 cells at different polarization states demonstrate specific targeting of the InvA497-functionalized liposomes to less polarized cells reflecting the status of inflamed cells. Moreover, when loaded with the anti-infective agent gentamicin and applied to HEp-2 cells infected with Y. pseudotuberculosis, InvA497-functionalized liposomes are able to significantly reduce the infection load relative to non-functionalized drug-loaded liposomes. This indicates a promising application of such a bacteriomimetic system for drug delivery to intracellular compartments. | |
dc.language.iso | en | en |
dc.title | Bacteriomimetic invasin-functionalized nanocarriers for intracellular delivery. | en |
dc.type | Article | en |
dc.contributor.department | Helmholtz Institute for Pharmaceutical Research Saarland (HIPS);Saarland University, Building A4.1, 66123 Saarbruecken, Germany. | en |
dc.identifier.journal | Journal of controlled release : official journal of the Controlled Release Society | en |
refterms.dateFOA | 2016-12-15T00:00:00Z | |
html.description.abstract | Intracellular bacteria invade mammalian cells to establish an infectious niche. The current work models adhesion and subsequent internalization strategy of pathogenic bacteria into mammalian cells to design a bacteriomimetic bioinvasive delivery system. We report on the surface functionalization of liposomes with a C-terminal fragment of invasin (InvA497), an invasion factor in the outer membrane of Yersinia pseudotuberculosis. InvA497-functionalized liposomes adhere to mammalian epithelial HEp-2 cell line at different infection stages with a significantly higher efficiency than liposomes functionalized with bovine serum albumin. Covalent attachment of InvA497 results in higher cellular adhesion than liposomes with physically adsorbed InvA497 with non-specific surface protein alignment. Uptake studies in HEp-2 cells indicate active internalization of InvA497-functionalized liposomes via β1-integrin receptor-mediated uptake mechanism mimicking the natural invasion strategy of Y. pseudotuberculosis. Uptake studies in Caco-2 cells at different polarization states demonstrate specific targeting of the InvA497-functionalized liposomes to less polarized cells reflecting the status of inflamed cells. Moreover, when loaded with the anti-infective agent gentamicin and applied to HEp-2 cells infected with Y. pseudotuberculosis, InvA497-functionalized liposomes are able to significantly reduce the infection load relative to non-functionalized drug-loaded liposomes. This indicates a promising application of such a bacteriomimetic system for drug delivery to intracellular compartments. |